Drug Profile
CLX 118
Alternative Names: CLX-118Latest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator Cellix Bio
- Developer Cellix Bio; Texas A&M University
- Class Antipyretics; Antirheumatics; Drug conjugates; Fatty acids; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Osteoarthritis